Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-117834
Filing Date
2024-11-13
Accepted
2024-11-13 17:30:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 10324
  Complete submission text file 0001104659-24-117834.txt   12116
Mailing Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840 203-404-1172
Nantahala Capital Management, LLC (Filed by) CIK: 0001472322 (see all company filings)

EIN.: 201151760 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 708 QUINCE ORCHARD RD SUITE 205 GAITHERSBURG MD 20878
Business Address 708 QUINCE ORCHARD RD SUITE 205 GAITHERSBURG MD 20878 844-972-0500
BiomX Inc. (Subject) CIK: 0001739174 (see all company filings)

EIN.: 823364020 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90744 | Film No.: 241455843
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)